Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Sun Pharma gets US approval to sell generic Exelon
BackBack

Sun Pharma gets US approval to sell generic Exelon

Sun Pharma gets US approval to sell generic Exelon

Premium

By Agencies

Sun Pharmaceutical Industries Ltd, India’s biggest drugmaker by market value, has got approval to sell its generic version of Novartis AG’s Exelon, in the US market with limited competition for six months, the drug maker said in a statement. Exelon is used to treat dementia.

The company has been allowed to sell capsules of rivastigmine tartrate, or generic Exelon, in four strengths. These dosages of Exelon have sales of about $200 million a year in the US, the company said.

Sun Pharma’s shares rose Rs27.80 , or 2.8%, to Rs1,007.50 on the Bombay Stock Exchange. The stock has gained 11% this year.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 23 Oct 2007, 04:04 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie